• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与早期和晚期植入式心脏复律除颤器感染相关的危险因素。

Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.

作者信息

Sohail Muhammad R, Hussain Salwa, Le Katherine Y, Dib Chadi, Lohse Christine M, Friedman Paul A, Hayes David L, Uslan Daniel Z, Wilson Walter R, Steckelberg James M, Baddour Larry M

机构信息

Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

出版信息

J Interv Card Electrophysiol. 2011 Aug;31(2):171-83. doi: 10.1007/s10840-010-9537-x. Epub 2011 Mar 2.

DOI:10.1007/s10840-010-9537-x
PMID:21365264
Abstract

AIMS

The infection rates of implantable cardioverter-defibrillators systems (ICDs) are higher than that of permanent pacemaker. Risk factors associated with ICD infection have not been characterized and are the subject of the current investigation.

METHODS

All patients who had an ICD implanted at Mayo Clinic Rochester between 1991 and 2008 were retrospectively reviewed. Each case of ICD infection was matched with two non-infected controls. Cases of ICD infection were further stratified by early- (≤ 6 months) versus late-onset (>6 months) infection. Multivariable analysis was performed to identify significant risk factors for ICD infection.

RESULTS

Sixty-eight patients with ICD infection and 136 matched controls met the inclusion criteria. Thirty-five cases presented with early-onset infection and 33 had late-onset device infection. Staphylococcal species were the most common pathogens in both groups of patients. Patients with early-onset infection were more likely to present with generator pocket infection (p = 0.02). Patients with multiple comorbid conditions (high Charlson index) tended to have longer hospital stay during implantation admission (p = 0.009). In a multivariable logistic regression model, the presence of epicardial leads (odds ratio (OR) = 9.7, p = 0.03) and postoperative complications at the generator pocket (OR = 27.2, p < 0.001) were significant risk factors for early-onset ICD infection, whereas longer duration of hospitalization at the time of implantation (2 days versus 1 day: OR = 33.1, p < 0.001; ≥ 3 days versus 1 day: OR = 49.0, p < 0.001) and chronic obstructive pulmonary disease (OR = 9.8, p = 0.02) were associated with late-onset infections.

CONCLUSIONS

Our study findings suggest that risk factors associated with early- and late-onset ICD infection are different. While circumstances that may increase the chances of pocket contamination in the perioperative period are more likely to be associated with early-onset ICD infection, overall poor health of the host may increase the likelihood of late-onset ICD infection. These factors should be considered when developing strategies to minimize risk of device infection.

摘要

目的

植入式心脏复律除颤器系统(ICD)的感染率高于永久性起搏器。与ICD感染相关的危险因素尚未明确,是当前研究的主题。

方法

对1991年至2008年在梅奥诊所罗切斯特分院植入ICD的所有患者进行回顾性研究。每例ICD感染患者与两名未感染的对照进行匹配。ICD感染病例进一步分为早期(≤6个月)与晚期(>6个月)感染。进行多变量分析以确定ICD感染的显著危险因素。

结果

68例ICD感染患者和136例匹配对照符合纳入标准。35例为早期感染,33例为晚期器械感染。葡萄球菌是两组患者中最常见的病原体。早期感染患者更易出现发生器囊袋感染(p = 0.02)。合并多种疾病(Charlson指数高)的患者在植入住院期间住院时间往往更长(p = 0.009)。在多变量逻辑回归模型中,心外膜导线的存在(比值比(OR)= 9.7,p = 0.03)和发生器囊袋术后并发症(OR = 27.2,p < 0.001)是早期ICD感染的显著危险因素,而植入时住院时间延长(2天对1天:OR = 33.1,p < 0.001;≥3天对1天:OR = 49.0,p < 0.001)和慢性阻塞性肺疾病(OR = 9.8,p = 0.02)与晚期感染相关。

结论

我们的研究结果表明,与早期和晚期ICD感染相关的危险因素不同。围手术期可能增加囊袋污染机会的情况更可能与早期ICD感染相关,而宿主整体健康状况差可能增加晚期ICD感染的可能性。在制定将器械感染风险降至最低的策略时应考虑这些因素。

相似文献

1
Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.与早期和晚期植入式心脏复律除颤器感染相关的危险因素。
J Interv Card Electrophysiol. 2011 Aug;31(2):171-83. doi: 10.1007/s10840-010-9537-x. Epub 2011 Mar 2.
2
Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.永久性起搏器和植入式心脏复律除颤器感染的管理与预后
J Am Coll Cardiol. 2007 May 8;49(18):1851-9. doi: 10.1016/j.jacc.2007.01.072. Epub 2007 Apr 23.
3
Permanent pacemaker and implantable cardioverter defibrillator infections: seven years of diagnostic and therapeutic experience of a single center.永久性心脏起搏器和植入式心脏复律除颤器感染:单中心 7 年的诊断和治疗经验。
Clin Cardiol. 2010 Jul;33(7):406-11. doi: 10.1002/clc.20765.
4
Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.在发生器囊袋处反复进行手术是植入式心脏复律除颤器感染的一个决定因素。
Clin Cardiol. 2017 Oct;40(10):892-898. doi: 10.1002/clc.22743. Epub 2017 Jun 21.
5
Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).预测金黄色葡萄球菌菌血症患者血管内装置感染风险(PREDICT-SAB)。
Circ Arrhythm Electrophysiol. 2015 Feb;8(1):137-44. doi: 10.1161/CIRCEP.114.002199. Epub 2014 Dec 12.
6
Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients.新植入经静脉植入式心脏复律除颤器 Medicare 患者的器械相关感染。
Heart Rhythm. 2021 Aug;18(8):1301-1309. doi: 10.1016/j.hrthm.2021.04.014. Epub 2021 Apr 19.
7
Risk factor analysis of permanent pacemaker infection.永久性起搏器感染的危险因素分析
Clin Infect Dis. 2007 Jul 15;45(2):166-73. doi: 10.1086/518889. Epub 2007 Jun 6.
8
Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.革兰氏阴性菌血症患者永久性起搏器或植入式心脏复律除颤器感染的发生率
Clin Infect Dis. 2006 Sep 15;43(6):731-6. doi: 10.1086/506942. Epub 2006 Aug 4.
9
Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study.骶神经调节后因感染而导致的器械取出的风险因素:一项多中心回顾性病例对照研究。
Am J Obstet Gynecol. 2018 Jul;219(1):78.e1-78.e9. doi: 10.1016/j.ajog.2018.04.005. Epub 2018 Apr 7.
10
Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.金黄色葡萄球菌菌血症患者的心血管植入式电子设备感染
Pacing Clin Electrophysiol. 2010 Apr;33(4):407-13. doi: 10.1111/j.1540-8159.2009.02565.x. Epub 2009 Sep 30.

引用本文的文献

1
The effect of age on the risk of early cardiac implantable electronic device infection.年龄对早期心脏植入式电子设备感染风险的影响。
Heart Rhythm O2. 2025 Apr 9;6(7):1039-1041. doi: 10.1016/j.hroo.2025.04.001. eCollection 2025 Jul.
2
Long-Term Complications Related to Cardiac Implantable Electronic Devices.与心脏植入式电子设备相关的长期并发症
J Clin Med. 2025 Mar 18;14(6):2058. doi: 10.3390/jcm14062058.
3
Cardiac Implantable Electronic Device Infections in Patients with Renal Insufficiency: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Contemporary management of cardiovascular implantable electronic device infections.心血管植入电子设备感染的当代管理。
Expert Rev Anti Infect Ther. 2010 Jul;8(7):831-9. doi: 10.1586/eri.10.54.
2
Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications.植入式心律转复除颤器反复更换与囊袋相关并发症风险增加有关。
Pacing Clin Electrophysiol. 2010 Aug;33(8):1013-9. doi: 10.1111/j.1540-8159.2010.02780.x. Epub 2010 Apr 27.
3
Perioperative management of anticoagulation in patients undergoing cardiac rhythm device procedures: a bridge to nowhere?
肾功能不全患者心脏植入式电子设备感染:一项系统评价和荟萃分析。
Diseases. 2024 Oct 10;12(10):247. doi: 10.3390/diseases12100247.
4
Incidence of Bacteremia in Patients Following Implantation of Cardiac Implantable Electronic Devices: A Danish Nationwide Cohort Study.心脏植入式电子设备植入患者的菌血症发生率:一项丹麦全国队列研究。
Open Forum Infect Dis. 2024 Sep 9;11(9):ofae515. doi: 10.1093/ofid/ofae515. eCollection 2024 Sep.
5
Unravelling staphylococcal small-colony variants in cardiac implantable electronic device infections: clinical characteristics, management, and genomic insights.解析心内植入电子设备感染中的葡萄球菌小菌落变异体:临床特征、处理和基因组见解。
Front Cell Infect Microbiol. 2024 Jan 8;13:1321626. doi: 10.3389/fcimb.2023.1321626. eCollection 2023.
6
Physician antibiotic hydration preferences for biologic antibacterial envelopes during cardiac implantable device procedures.心脏植入式设备手术期间医生对生物抗菌包膜的抗生素水化偏好。
Front Cardiovasc Med. 2022 Dec 22;9:1006091. doi: 10.3389/fcvm.2022.1006091. eCollection 2022.
7
Risk Scores for Cardiac Implantable Electronic Device Infection: Which One to Believe In?心脏植入式电子设备感染的风险评分:该相信哪一个?
J Clin Med. 2022 Nov 4;11(21):6556. doi: 10.3390/jcm11216556.
8
Risk factors for cardiac implantable electronic device infections: a nationwide Danish study.心脏植入式电子设备感染的危险因素:一项全国性丹麦研究。
Eur Heart J. 2022 Dec 14;43(47):4946-4956. doi: 10.1093/eurheartj/ehac576.
9
Process mapping strategies to prevent subcutaneous implantable cardioverter-defibrillator infections.预防皮下植入式心脏复律除颤器感染的流程映射策略。
J Cardiovasc Electrophysiol. 2022 Jul;33(7):1628-1635. doi: 10.1111/jce.15566. Epub 2022 Jun 9.
10
Temporal and Microbiological Analysis of Cardiac Implantable Electrical Device Infections - A Retrospective Study.心脏植入式电子装置感染的时间和微生物学分析——一项回顾性研究
Circ Rep. 2021 Aug 21;3(9):488-496. doi: 10.1253/circrep.CR-21-0095. eCollection 2021 Sep 10.
心律装置手术患者围手术期抗凝管理:通往虚无之桥?
Pacing Clin Electrophysiol. 2010 Apr;33(4):383-4. doi: 10.1111/j.1540-8159.2010.02697.x. Epub 2010 Feb 19.
4
Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.持续华法林治疗优于在接受起搏器和除颤器植入的患者中断华法林治疗并用或不用桥接抗凝治疗。
Heart Rhythm. 2010 Jun;7(6):745-9. doi: 10.1016/j.hrthm.2010.02.018. Epub 2010 Feb 20.
5
Perioperative management of anticoagulation during device implantation-the UK perspective.器械植入围手术期抗凝管理——英国视角
Pacing Clin Electrophysiol. 2010 Apr;33(4):389-93. doi: 10.1111/j.1540-8159.2009.02683.x. Epub 2010 Jan 27.
6
The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.华法林、阿司匹林和氯吡格雷在围手术期的持续使用与器械植入后血肿形成发生率之间的关系。
Pacing Clin Electrophysiol. 2010 Apr;33(4):385-8. doi: 10.1111/j.1540-8159.2009.02674.x. Epub 2010 Jan 4.
7
Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.起搏器和心脏复律除颤器植入前抗生素预防的疗效:一项大型、前瞻性、随机、双盲、安慰剂对照试验的结果
Circ Arrhythm Electrophysiol. 2009 Feb;2(1):29-34. doi: 10.1161/CIRCEP.108.795906. Epub 2009 Feb 10.
8
Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.金黄色葡萄球菌菌血症患者的心血管植入式电子设备感染
Pacing Clin Electrophysiol. 2010 Apr;33(4):407-13. doi: 10.1111/j.1540-8159.2009.02565.x. Epub 2009 Sep 30.
9
Continue or withhold oral anticoagulation in high-risk patients undergoing pacemaker or ICD implantation.对于接受起搏器或植入式心脏复律除颤器(ICD)植入的高危患者,是继续还是停用口服抗凝药。
Eur Heart J. 2009 Aug;30(15):1828a-1828c. doi: 10.1093/eurheartj/ehn491.
10
Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation.接受起搏器植入术的机械心脏瓣膜患者的围手术期抗凝治疗。
Europace. 2009 Sep;11(9):1183-7. doi: 10.1093/europace/eup212. Epub 2009 Aug 6.